Neuroone Med Technologies Co.
13F holders, Q3 2024 (September 30)21holders +3
6new positions
3sold out
$0.99avg. 13F price*
At the end of Q3 2024, 21 institutions reported holding Neuroone Med Technologies Co. in their 13F filings, up 3 from Q2 2024. 6 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($910K), Nantahala Capital Management, LLC ($791K) and Geode Capital Management, LLC ($281K).
- Company
- Neuroone Med Technologies Co.
- CUSIP
- 64130M209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $97K |
| Exits | 3 | $167K |
All 13F filers, Q2 2024 → Q3 2024: 122,827 shares bought and 434,720 shares sold, net −311,893 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Vanguard Group Inc. | 0.00% | No change | 919,528 | $910K |
| Nantahala Capital Management, LLC | 0.07% | Reduce -16.0% | 798,762 | $791K |
| Geode Capital Management, LLC | 0.00% | Add +9.7% | 283,855 | $281K |
| Perkins Capital Management Inc. | 0.14% | No change | 150,000 | $149K |
| State Street Corp. | 0.00% | No change | 59,499 | $59K |
| Blair William & Co. | 0.00% | New | 55,556 | $55K |
| MAI Capital Management | 0.00% | No change | 50,000 | $50K |
| Northern Trust Corp. | 0.00% | No change | 30,281 | $30K |
| XTX Topco Ltd | 0.00% | New | 26,408 | $26K |
| Princeton Global Asset Management LLC | 0.00% | No change | 16,833 | $17K |
| Marcum Wealth, LLC | 0.00% | New | 12,000 | $12K |
| Virtu Financial LLC | 0.00% | Reduce -45.5% | 10,435 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -61.9% | 4,346 | $4K |
| Farther Finance Advisors, LLC | 0.00% | New | 2,500 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,259 | $1K |
| Simplex Trading, LLC | 0.00% | New | 1,033 | $1K |
| Nemes Rush Group LLC | 0.00% | No change | 433 | $520 |
| Wells Fargo & Company | 0.00% | New | 333 | $330 |
| Bank of America Corp. | 0.00% | Add +6.0% | 229 | $227 |
| UBS Group AG | 0.00% | Reduce -99.8% | 108 | $107 |
| JPMorgan Chase & Co. | 0.00% | Add +21.1% | 69 | $68 |
"% of holder's portfolio" is NEUROONE MED TECHNOLOGIES CO's weight in each manager's 13F, not the share of Neuroone Med Technologies Co. the manager owns.